However, in a recent study, we demonstrated that the fasting-mediated enhancement of endocrine therapy activity in hormone receptor-positive breast cancer (HR+ breast cancer) also relies on the ability of fasting to blunt circulating insulin and leptin concentrations [2]. The gene discussed is INS; the disease is breast carcinoma.